Beijing Bohui Innovation Biotechnology Group Co., Ltd. Share Price
Equities
300318
CNE000001QR4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 CNY | +8.16% | +12.15% | -17.15% |
Sales 2022 | 796M 110M 8.77B | Sales 2023 | 1.05B 144M 11.52B | Capitalization | 5.1B 704M 56.15B |
---|---|---|---|---|---|
Net income 2022 | -78M -10.77M -859M | Net income 2023 | -24M -3.31M -264M | EV / Sales 2022 | 6.85 x |
Net Debt 2022 | 674M 93.1M 7.43B | Net Debt 2023 | 703M 97.1M 7.75B | EV / Sales 2023 | 5.55 x |
P/E ratio 2022 |
-61
x | P/E ratio 2023 |
-205
x | Employees | 1,773 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.67% |
1 day | +8.16% | ||
1 week | +12.15% | ||
Current month | -3.90% | ||
1 month | -3.90% | ||
3 months | -3.90% | ||
6 months | -14.69% | ||
Current year | -17.15% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Jiang
CEO | Chief Executive Officer | 54 | 16/03/20 |
Hai Feng Dong
DFI | Director of Finance/CFO | 40 | 28/06/20 |
Jiang Hong Du
CHM | Chairman | 56 | 25/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jiang Hong Du
CHM | Chairman | 56 | 25/06/01 |
Jun Ban
BRD | Director/Board Member | 57 | 28/06/20 |
Zhi Wei Shen
CHM | Chairman | 46 | 31/05/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 5.17 | +8.16% | 21,281,940 |
26/04/24 | 4.78 | 0.00% | 7,431,750 |
25/04/24 | 4.78 | +2.36% | 8,360,084 |
24/04/24 | 4.67 | +0.86% | 5,519,484 |
23/04/24 | 4.63 | +0.43% | 5,717,200 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.15% | 583M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+57.41% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+7.57% | 8.81B | |
-10.41% | 8.24B |
- Stock Market
- Equities
- 300318 Stock